Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Renal Cell Carcinoma (RCC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT03592472
What this trial is testing

Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)

Who this might be right for
Renal Cell Carcinoma
Xynomic Pharmaceuticals, Inc. 413
Early research (Phase 1)UnknownNCT01381822
What this trial is testing

Dose-Escalation Study of TH-302 in Combination With Sunitinib to Treat Patients With Advanced Renal Cell Carcinoma,Gastrointestinal Stromal Tumors and Pancreatic Neuroendocrine Tumors

Who this might be right for
Advanced Renal Cell CarcinomaGastrointestinal Stromal TumorsPancreatic Neuroendocrine Tumors
Threshold Pharmaceuticals 58
Early research (Phase 1)Study completedNCT00944905
What this trial is testing

Study of MDX-1203 in Subjects With Advanced/Recurrent Clear Cell Renal Cell Carcinoma (ccRCC) or Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL)

Who this might be right for
Renal Cell CarcinomaNon-hodgkin's Lymphoma
Bristol-Myers Squibb 46
Testing effectiveness (Phase 2)Looking for participantsNCT06794229
What this trial is testing

Neoadjuvant Zanzalintinib Plus Nivolumab in Patients With Locally Advanced and/or Inoperable Clear Cell Renal Cell Carcinoma With or Without Non-measurable Metastasis

Who this might be right for
Locally Advanced Renal Cell Carcinoma
Qian Qin 69
Testing effectiveness (Phase 2)Active Not RecruitingNCT05501054
What this trial is testing

Phase 1b/2 Trial of Ipilimumab, Nivolumab, and Ciforadenant (Adenosine A2a Receptor Antagonist) in First-line Advanced Renal Cell Carcinoma.

Who this might be right for
Renal Cell Carcinoma
M.D. Anderson Cancer Center 50
Early research (Phase 1)Ended earlyNCT02543645
What this trial is testing

Varlilumab and Atezolizumab in Patients With Advanced Cancer

Who this might be right for
Carcinoma, Renal CellKidney DiseasesKidney Neoplasms+11 more
Celldex Therapeutics 18
Testing effectiveness (Phase 2)UnknownNCT04049344
What this trial is testing

Decitabine Combined With Oxaliplatin in Patients With Advanced Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Zhejiang Cancer Hospital 25
Testing effectiveness (Phase 2)Looking for participantsNCT06863311
What this trial is testing

Trial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCC

Who this might be right for
Advanced Renal Cell CarcinomaMetastatic Renal Cell CarcinomaClear Cell Renal Cell Carcinoma
Karie Runcie 70
Early research (Phase 1)Ended earlyNCT03145909
What this trial is testing

A Study Evaluating the Safety, Pharmacokinetics and Anti-Tumor Activity of ABBV-176 in Subjects With Advanced Solid Tumors Likely to Express Prolactin Receptor (PRLR)

Who this might be right for
Advanced Solid Tumors Cancer
AbbVie 19
Large-scale testing (Phase 3)Looking for participantsNCT07489495
What this trial is testing

A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)

Who this might be right for
Carcinoma, Renal Cell
Merck Sharp & Dohme LLC 758
Testing effectiveness (Phase 2)Study completedNCT02002312
What this trial is testing

Phase II Study of Lutetium-177 Labeled Girentuximab in Patients With Advanced Renal Cancer

Who this might be right for
Metastatic Clear Cell Renal Cell Carcinoma
Radboud University Medical Center 14
Early research (Phase 1)Study completedNCT02014636
What this trial is testing

Safety and Efficacy Study of Pazopanib and MK 3475 in Advanced Renal Cell Carcinoma (RCC; KEYNOTE-018)

Who this might be right for
Carcinoma, Renal Cell
Novartis Pharmaceuticals 42
Not applicableStudy completedNCT01351571
What this trial is testing

An Observational Study of Avastin (Bevacizumab) in Combination With Interferon Alpha-2a as First-Line Treatment in Patients With Advanced and/or Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Cancer
Hoffmann-La Roche 5
Testing effectiveness (Phase 2)Study completedNCT02724020
What this trial is testing

MLN0128 and MLN0128 + MLN1117 Compared With Everolimus in the Treatment of Adults With Advanced or Metastatic Clear-Cell Renal Cell Carcinoma

Who this might be right for
Clear-cell Metastatic Renal Cell Carcinoma
Millennium Pharmaceuticals, Inc. 96
Large-scale testing (Phase 3)Active Not RecruitingNCT05678673
What this trial is testing

Study of XL092 + Nivolumab vs Sunitinib in Subjects With Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma

Who this might be right for
Non-Clear Cell Renal Cell Carcinoma
Exelixis 317
Testing effectiveness (Phase 2)Study completedNCT00005045
What this trial is testing

Carboxyamidotriazole in Treating Patients With Advanced Kidney Cancer

Who this might be right for
Kidney Cancer
Eastern Cooperative Oncology Group
Large-scale testing (Phase 3)Not Yet RecruitingNCT07338981
What this trial is testing

The Impact of Time-of-day-Dependent Administration of Nivolumab-Ipilimumab (ICI/ICI) Combination on Overall Survival in Adults With Advanced Kidney Cancer: A Pragmatic Multicenter, Randomized Controlled Trial.

Who this might be right for
Advanced Kidney Cancer
Guliz Ozgun 142
Testing effectiveness (Phase 2)Study completedNCT00079612
What this trial is testing

Study of Nexavar (Sorafenib, BAY 43-9006) in Patients With Advanced Refractory Cancer

Who this might be right for
Carcinoma, Renal Cell
Bayer 501
Not applicableStudy completedNCT05361434
What this trial is testing

The Effectiveness of Cabozantinib in Combination With Nivolumab as First-line Treatment of Advanced Renal Cell Carcinoma (aRCC) in Adults

Who this might be right for
Advanced Renal Cell Carcinoma
Ipsen 311
Early research (Phase 1)Ended earlyNCT05861947
What this trial is testing

Clinical Trial of AUR106 in Patients With Relapsed Advanced Malignancies

Who this might be right for
RelapseAdvanced Malignant NeoplasmNon Small Cell Lung Cancer+5 more
Aurigene Discovery Technologies Limited 21
Next Page